Stay up-to-date with the Cipla Stock Liveblog, your trusted source for real-time updates and thorough analysis of a prominent ...

AM(IST)on Friday in a weak market. J B Chemicals & Pharmaceuticals Ltd.(up 1.35 per cent), Glenmark Pharmaceuticals Ltd.(up 1 ...

Cipla faces headwinds but remains resilient with strong product portfolio, robust earnings growth potential, and reasonable ...

Stay updated with the Cipla Stock Liveblog, your one-stop destination for real-time information and analysis of a leading ...

An index of Indian pharmaceutical company shares slid 2% to its lowest ... January 28, 2025 India's Cipla beats Q3 profit view as strong domestic demand offset weak US sales Cipla , one of ...

Formosa Pharmaceuticals and Cipla Limited have entered into an exclusive licensing agreement for the commercialization of ...

Cipla Limited is an Indian multinational pharmaceutical company that is headquartered in Mumbai, Maharashtra. The company is primarily known for producing generic drugs for various therapeutic uses.

According to Cipla, the regulatory clearance serves as an important landmark in the Company's journey, allowing it to expand the depth of its oncology portfolio and its foothold in the US market ...

Under this agreement, Cipla has exclusive rights to market the innovative treatment for post-operative inflammation and pain ...

Under this agreement, Cipla has exclusive rights to market the innovative treatment for post-operative inflammation and pain ...

An analyst from Axis Securities said that Dr Reddy's Labs has shown signs of weakness following the formation of a double top ...

This new steroid represents a significant advancement in the ophthalmic market, extending notable patient benefits, the company stated.